उच्चतम न्यायालय ने सनोफी इंडिया लिमिटेड बनाम सीबीआई मामले में फैसला सुनाया कि प्रारंभिक चरण में किसी प्राकृतिक व्यक्ति (natural person) को अभियुक्त (accused) बनाए बिना भी किसी कॉर्पोरेट संस्था के खिलाफ आपराधिक अभियोजन (criminal prosecution) चलाया जा सकता है।
Court: Supreme Court of India
Bench: Justice J.B. Pardiwala and Justice Manoj Misra
Case Title: Sanofi India Ltd. v. Central Bureau of Investigation (CBI)
Date of Judgment: September 7, 2026
Statutory Provisions: Section 482, Code of Criminal Procedure, 1973 (CrPC); Indian Penal Code, 1860 (IPC); Prevention of Corruption Act, 1988
Executive Summary
In a landmark precedent on corporate criminal jurisprudence, the Supreme Court of India held that a commercial entity can face criminal trial for offences requiring mens rea (guilty intent), even if the investigating agency has neither identified nor arraigned as an accused the specific natural person or employee through whom the corporate body acted.
Dismissing an appeal filed by Sanofi India Ltd. against a Karnataka High Court order, the Division Bench ruled that the absence of an identified human agent at the stage of framing a chargesheet or filing a quashing petition under Section 482 CrPC is not fatal to the prosecution. Authoring the 98-page judgment, Justice J.B. Pardiwala emphasized that the chargesheet need only reveal, prima facie, that the corporate entity committed the offence through its institutional decisions, transactional dealings, or collective conduct. To evaluate corporate liability moving forward, the Apex Court established a sequential, three-stage framework of attribution.
Factual Background & Procedural History
The matter stems from a probe initiated by the Central Bureau of Investigation (CBI) regarding the procurement of pharmaceutical supplies for the Rare Materials Project of the Bhabha Atomic Research Centre (BARC) during the financial periods 2011–12, 2013–14, and 2015–16.
The CBI filed a chargesheet alleging that a Scientific Officer (Medical) at BARC, Dr. P. Anand, entered into a criminal conspiracy with private pharmaceutical manufacturers, including Sanofi India Ltd., to procure medicines at inflated costs and in quantities far exceeding actual institutional requirements. The prosecution alleged that Dr. Anand favored Sanofi India Ltd. by misclassifying its pharmaceutical products as proprietary items—thereby bypassing competitive bidding processes and rejecting lower tenders—which caused an estimated loss of ₹3.53 lakh to the public exchequer. Additionally, the chargesheet asserted that Dr. Anand accepted illegal gratification amounting to ₹42,750 from Sanofi.
While Sanofi India Ltd. was named as an accused corporate entity in the chargesheet, the CBI did not identify or arraign any individual officer, director, or employee of Sanofi as a co-accused.
Sanofi approached the Karnataka High Court under Section 482 CrPC seeking to quash the criminal proceedings, contending that an artificial juristic person cannot be prosecuted for offences involving mens rea unless a natural person—representing the company’s "alter ego" or "directing mind"—is identified and arraigned alongside it. Following the High Court’s refusal to quash the chargesheet, Sanofi appealed to the Supreme Court.
Key Legal Principles & Rulings
1. Threshold Requirement Under Section 482 CrPC:
The Supreme Court clarified that at the preliminary stage of quashing a case, the prosecution is not required to establish the specific individual who acted as the "alter ego" of the corporate body. It is sufficient if the chargesheet discloses on its face that the corporate entity committed the act through its corporate acts. Specifying particular individuals goes to the evidentiary strength during trial rather than the threshold validity of the prosecution.
2. Investigation Realities in Corporate Fraud:
The Court observed that requiring the strict identification of human actors at the threshold stage would stifle legitimate white-collar prosecutions. Complainants and investigating agencies often possess clear evidence that a corporation benefited from or committed a wrongful act, while lacking immediate access to internal corporate hierarchies or delegation records to pinpoint the exact officer responsible.
3. Indivisibility of Mens Rea:
The Bench reiterated that while a corporation acquires mens rea only through attribution from a natural person, the complete requisite mental state must reside in at least one human agent. It cannot be artificially constructed by stitching together isolated or partial states of mind across different employees.
4. Punishment Standard for Corporate Entities:
Reaffirming the principle established in Standard Chartered Bank v. Directorate of Enforcement, the Court held that a corporate entity can be prosecuted for offences carrying mandatory imprisonment provided the statute also prescribes a fine. Where imprisonment cannot be enforced against an artificial entity, the penalty of a fine alone will be imposed upon conviction.
The Three-Stage Attribution Framework
To govern how an individual’s actions and mental state are attributed to a corporate body for offences involving mens rea, the Supreme Court laid down a hierarchical, transaction-specific test:
| Stage | Test Name | Criteria & Judicial Inquiry |
| 1 | Primary Authority Test | Courts must examine whether the corporate entity's constitutional documents (such as Articles of Association) or statutory company rules explicitly vest the person with the legal power to perform the act in question. |
| 2 | Delegation Test | If Stage 1 does not apply, courts must evaluate whether that operational authority was expressly or impliedly delegated to the individual with sufficient discretion and independence, regardless of their formal title. |
| 3 | Statutory Purpose Test | Where primary authority and delegation tests yield no clarity, courts may formulate a special rule of attribution based on the policy, statutory purpose, and intent of the governing criminal act. |
The Court emphasized that this test operates on a transaction-by-transaction basis rather than seeking a single, permanent "directing mind" for all operations of the corporate entity.
Conclusion & Order
Holding that the material on record prima facie established that natural persons acted on behalf of Sanofi India Ltd. in the BARC procurement transactions and that the surrounding circumstances did not render mens rea inherently improbable, the Supreme Court dismissed the appeal and directed the matter to proceed to trial.
Discription: The Supreme Court of India ruled in Sanofi India Ltd. v. CBI that a company can face criminal prosecution for offences requiring mens rea (guilty intent) even if no individual employee or official is identified or named as an accused in the chargesheet. Dismissing Sanofi’s quashing petition under Section 482 CrPC, a Division Bench held that a chargesheet is valid if it prima facie discloses corporate wrongdoing through company decisions, transactions, or conduct. Specifying particular individuals affects evidentiary strength at trial, not initial prosecution validity. To evaluate corporate liability, the Court established a three-stage attribution framework—examining primary constitutional authority, delegated operational control, and statutory purpose—enabling trial courts to attribute an individual’s mental state to a corporation on a transaction-specific basis.